Sunscreen Ingredient Legislation Could Ride Wave Of Momentum
This article was originally published in The Rose Sheet
Legislators and stakeholders are optimistic that the Sunscreen Innovation Act, which calls for an acceleration of FDA’s review of sunscreen active-ingredient time-and-extent applications, will pass this year. The House version of the bill is expected to advance first.
You may also be interested in...
The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.
Without swift FDA action on eight sunscreen filters pending review, legislators intend to introduce a bill to alter the agency’s sunscreen approval process. House members questioned FDA Center for Drug Evaluation and Research Director Janet Woodcock on the status of the applications, some of which have been under agency review for more than 10 years.
As European industry’s concerns grow about “politicization” of regulatory programs, the United States-Mexico-Canada Agreement’s cosmetics annex directs regulatory authorities pursuing new rules to give due consideration to scientific and technical guidance documents developed through international collaboration.